
Latest in InvestEU
EIB's €150M Théa Deal: A Test for Europe's Pharma Ambitions
The European Investment Bank's new financing for Théa highlights Europe's push to strengthen pharmaceutical research and manufacturing. But can institutional funding translate into innovation, competitiveness and investor confidence?
Patricio De GaetanoPatricio De Gaetano••5 min read
